Today, the U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.
Watch the video message below from Sandra C. Raymond, President and Chief Executive Officer of the Lupus Foundation of America (LFA), regarding the FDA’s decision:
For more information on the significance of this groundbreaking announcement, visit LFA’s website.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment